Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityNo recent work listed

Ang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6720-0785; OpenAlex author ID A5100413574. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

  1. TMEM176A acts as a tumor suppressor gene in pancreatic cancer by inhibiting ERK signaling. Co-author PMID 33593482↗
  2. MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Co-author DOI 10.1158/1078-0432.ccr-12-3092↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Feng Cao · 1 shared paper, 2020 · strength 0.13
  2. Fei Li · 1 shared paper, 2020 · strength 0.13
  3. Yulin Guo · 1 shared paper, 2020 · strength 0.13
  4. Marcia Irene Canto · 1 shared paper, 2013 · strength 0.04
  5. Haeryoung Kim · 1 shared paper, 2013 · strength 0.04
  6. Jun Yu · 1 shared paper, 2013 · strength 0.04
  7. Christopher Lee Wolfgang · 1 shared paper, 2013 · strength 0.04
  8. Michael Goggins · 1 shared paper, 2013 · strength 0.04
  9. Ralph H. Hruban MD · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.